美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA215049"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
31722-019-31 31722-019 HUMAN PRESCRIPTION DRUG Diatrizoate Meglumine and Diatrizoate Sodium Diatrizoate Meglumine and Diatrizoate Sodium SOLUTION ORAL; RECTAL 20231117 N/A ANDA ANDA215049 Camber Pharmaceuticals, Inc. DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM 660 mg/mL; 100 mg/mL 24 BOTTLE in 1 BOX (31722-019-31) / 30 mL in 1 BOTTLE
31722-019-32 31722-019 HUMAN PRESCRIPTION DRUG Diatrizoate Meglumine and Diatrizoate Sodium Diatrizoate Meglumine and Diatrizoate Sodium SOLUTION ORAL; RECTAL 20231117 N/A ANDA ANDA215049 Camber Pharmaceuticals, Inc. DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM 660 mg/mL; 100 mg/mL 12 BOTTLE in 1 BOX (31722-019-32) / 120 mL in 1 BOTTLE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase